These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20166103)

  • 1. Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.
    Gill JK; Wilkens LR; Pollak MN; Stanczyk FZ; Kolonel LN
    Prostate; 2010 Jun; 70(8):906-15. PubMed ID: 20166103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
    Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
    Li L; Yu H; Schumacher F; Casey G; Witte JS
    Cancer Causes Control; 2003 Oct; 14(8):721-6. PubMed ID: 14674736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
    Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Grønbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quirós JR; Ardanaz E; Navarro C; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1121-7. PubMed ID: 17548673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.
    Miles FL; Goodman PJ; Tangen C; Torkko KC; Schenk JM; Song X; Pollak M; Thompson IM; Neuhouser ML
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28417914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.
    Cao Y; Nimptsch K; Shui IM; Platz EA; Wu K; Pollak MN; Kenfield SA; Stampfer MJ; Giovannucci EL
    Int J Cancer; 2015 May; 136(10):2418-26. PubMed ID: 25348852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer.
    Rowlands MA; Holly JM; Hamdy F; Phillips J; Goodwin L; Marsden G; Gunnell D; Donovan J; Neal DE; Martin RM
    Cancer Causes Control; 2012 Feb; 23(2):347-54. PubMed ID: 22183619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.
    Wolk A; Mantzoros CS; Andersson SO; Bergström R; Signorello LB; Lagiou P; Adami HO; Trichopoulos D
    J Natl Cancer Inst; 1998 Jun; 90(12):911-5. PubMed ID: 9637140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
    Wu AH; Whittemore AS; Kolonel LN; John EM; Gallagher RP; West DW; Hankin J; Teh CZ; Dreon DM; Paffenbarger RS
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):735-41. PubMed ID: 8672990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.
    Platz EA; Pollak MN; Leitzmann MF; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Causes Control; 2005 Apr; 16(3):255-62. PubMed ID: 15947877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Sieri S; Vineis P; Palli D; Quirós JR; Ardanaz E; Chirlaque MD; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R
    Int J Cancer; 2007 Sep; 121(6):1331-8. PubMed ID: 17514649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between risk of biliary tract cancer and circulating IGF (Insulin-like Growth Factor) -I, IGF-II or IGFBP-3 (IGF-binding Protein-3): A nested case-control study in a large scale cohort study in Japan.
    Yagyu K; Kikuchi S; Lin Y; Ishibashi T; Obata Y; Kurosawa M; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():63-7. PubMed ID: 20553084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
    Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindstrom S; Schumacher FR; Cox D; Hsing AW; Ma J; Severi G; Albanes D; Virtamo J; Boeing H; Bueno-de-Mesquita HB; Johansson M; Quirós JR; Riboli E; Siddiq A; Tjønneland A; Trichopoulos D; Tumino R; Gaziano JM; Giovannucci E; Hunter DJ; Kraft P; Stampfer MJ; Giles GG; Andriole GL; Berndt SI; Chanock SJ; Hayes RB; Key TJ
    Am J Epidemiol; 2012 May; 175(9):926-35. PubMed ID: 22459122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.